Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. People
    3. Susanna C. Benn, Ph.D.People
    1. Home
    2. People
    3. Susanna C. Benn, Ph.D.People

    Susanna C. Benn, Ph.D.

    Associate


    • Boston
    • Office617.345.1019
    • sbenn@nixonpeabody.com
    • Download vCard
    • Share
    • LinkedIn Profile

    Introduction

    Dr. Susanna Benn is a patent associate in the Patent group focusing on the life sciences industry. She represents academic and nonprofit institutions, biotech and startup companies and large pharma to counsel clients in a diverse range of patent prosecution-related issues and strategies in the areas of diagnostics, therapeutics and pharmaceuticals.

    Practice Areas

    Intellectual PropertyLife SciencesNon-Compete & Trade Secrets

    Industries

    Healthcare

    My focus

    Much of my work focuses on patent prosecution for innovative technologies, the early phases of development and strategic management of clients’ patent portfolios including patent opinion work.

    Patent Prosecution

    I help clients obtain valuable patent protection of their innovative technologies in the U.S. and worldwide. In addition to my 10+ years of research experience in neurobiology and stem cells, I have deep experience in the areas of regenerative medicine, personalized medicine, diagnostic devices, pharmacogenomics, companion diagnostics, vaccines, cancer therapeutics, drug delivery systems, microfluidic devices, plasmonic nanoarrays and RNAi technology.

    Patent Portfolio management

    As a growing number of technologies are transferred from academic institutions to be commercialized by startups and biotech companies, I work closely with my clients in the strategic development and management of their IP portfolio and provide competitive IP analysis for start-up companies and academic institutions to ensure their patent portfolio aligns with their business goals and plans. My work as a team member in patent interferences and litigation cases enables me to assess patent portfolios from both a prosecutor’s and litigator’s perspective.

    Opinion work

    I provide guidance on Freedom to Operate, patentability and validity/infringement analysis for a variety of clients and perform due diligence for acquisitions and financing for angel investors and VC clients. I believe the importance of a strategically developed and managed global patent portfolio will have an instrumental impact on the successful commercialization of life science innovations going forward given the increasingly competitive nature of the industry.

    Looking ahead

    I believe the importance of a strategically developed and managed global patent portfolio will have an instrumental impact on the successful commercialization of life science innovations going forward given the increasingly competitive nature of the industry.

    Insights

    • “Equity in Innovation: Overcoming Barriers to Women Engaging in Innovation and the Patent System,” Boston University Office of Research, Webinar, September 24, 2020

    Representative experience

    Susanna received her Ph.D. from University College London, specializing in Neuroscience under the direction of Dr. Clifford Woolf at Massachusetts General Hospital, Harvard Medical School. Her research focused in the field of pain research and neuronal survival. Following completion of her graduate studies, Susanna joined the laboratory of Dr. Robert Brown at Massachusetts General Hospital, Harvard Medical School, where her post-doctoral research focused on therapeutic strategies for neurodegenerative diseases and ALS. Throughout her academic career, Susanna gained valuable knowledge and skill in the areas of neurodegenerative diseases, stem cells, and therapeutic drug delivery. Susanna has presented her work in numerous scientific journals and at international meetings, and has several review articles from her research. Prior to graduate school, Susanna was a research assistant at GlaxoSmithKline in the UK.


    Admitted to practice

    U.S. Patent and Trademark Office
    Massachusetts

    Education

    Suffolk University Law School, J.D., 2011
    University College London, UK, Ph.D., 2002, Neuroscience
    University of Bristol, UK, B.Sc., 1998 , honors, Biochemistry

    Insights And Happenings

    View All
    • Alert

      State sovereign immunity, like tribal sovereign immunity, does not protect from IPR proceedings

      July 3, 2019
    View All

    Professionals in the Practice Area

    View All
    • Seth D. Levy

      Partner / Leader, Intellectual Property Practice / Co-chair, Life Sciences Practice
      • Los Angeles
      • Office:213.629.6161
      • slevy@nixonpeabody.com
      Seth D. Levy
    • Ravinderjit Braich, Ph.D.

      Partner
      • Boston
      • Office:617.345.1089
      • rbraich@nixonpeabody.com
      Ravinderjit Braich, Ph.D.
    • Jennette W. Psihoules

      Counsel
      • Washington DC
      • Office:202.585.8385
      • jpsihoules@nixonpeabody.com
      Jennette W. Psihoules
    • Janet M. Garetto

      Partner
      • Chicago
      • Office:312.425.8514
      • jgaretto@nixonpeabody.com
      Janet M. Garetto
    • Andrew Y. Choung

      Partner
      • Los Angeles
      • Office:213.629.6166
      • achoung@nixonpeabody.com
      Andrew  Y. Choung
    View All

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL